World Cancer Conference (WCC-2017)

Topics

• Lymphoma
  • Non-Hodgkins lymphoma
  • Lymphoid neoplasia
  • Lymphoma treatment therapies
  • Hodgkins lymphoma
• Breast Cancer
  • Ductal Carcinoma in Situ
  • Invasive Breast Cancer stages (I-IV)
  • Inflammatory Breast Cancer
  • Lobular Carcinoma in situ
  • 2Colorectal Cancer
  • Breast Cancer during Pregnancy
  • Robotic Surgery
  • Laproscopic surgery
  • Targeted Therapy
  • Chemotherapy
  • Cancer Vaccines
• Blood Cancer
  • Hairy cell leukemia
  • Acute lymphocytic leukemia
  • Acute promeylocytic leukemia
  • Juvenile myelomonocytic leukemia
  • Risk Factors
  • Chronic lymphocytic leukemia
  • Diagnosis and treatment therapies
• Lung Cancer
  • Immunotherapy
  • Advanced bronchoscopic techniques
  • Radiotherapy
  • Oncogenic Drivers
• Cancer Treatment and Prevention
  • Chemotherapy
  • Radiation
  • Hormone Therapy
  • Immunotherapy
  • Gene Therapy
• Gynecologic cancer
  • Treatment therapies and side effects
  • Types of cancer
  • Diagnosis methods
  • Endometriosis
• Stem Cell Transplants
  • Allogeneic Stem Cell Transplant
  • Autologous Stem Cell Transplant
  • Syngeneic Stem Cell Transplants
  • Mini Transplants
  • Half-Matched transplants
• Herbal Treatments for Cancer
  • Herbal Medicines for specific Cancers
  • Herbal Therapies
  • Safety of Herbal Medicine
• Cancer Biomarkers
  • Prognosis and treatment predictions
  • Risk assessment
  • Types of Cancer Biomarkers
  • Pharmacodynamics and Pharmacokinetics
  • Uses of Biomarkers in cancer research
• Cancer Diagnosis
  • Mammography
  • Magnetic Resonance Imaging (MRI)
  • Sigmoidoscopy
  • Pap test
  • Tumor Marker test
  • Ultra sound
  • Types of Endoscopy
• Cancer Genomics
  • Genomic Instability
  • Neuroendocrine Tumors
  • Epigenetic Alterations in cancer
  • Drug Combination Trails for cancer
  • Driver mutations
• Metastatic Cancer
  • Metastatic lesion
  • Anti metastasis Therapies
  • Organ-Specific Targets
  • Metastasis Diagnosis and Treatment
• Skin cancer
  • Sarcoma
  • Melanoma and cutaneous oncology
  • Cuteneous lymphoma
  • Mohs surgery
  • Soft tissue Sarcoma

Who should Attend

• Psychiatrists
• Internists
• Cancer Professionals
• Family Physicians
• Physical therapists
• Paramedics working in HIV
• Lecturers
• Diagnostic company induviduals
• University Department Chairs
• University Deans
• University Assistant professors Immunology
• University faculties Cancer and Immunology
• Research scholars
• University Associate professors in Immunology
• Phd Students
• Research assistants
• Clinicians
• Post Doc Students
• Researchers
• Lab Technichians
• Scientists
• Business development officers
• Chief executive officers
• Executive Directors
• Cancer Company Presidents
• Cancer Company CEOs
• Cancer Company Co-Founders and Founders
• Cancer Company Vice Presidents
• Editoriual Board Members of related Journals
• Neurology/Neuroimmunology Journals Editors
• General Practitioners
• Directors of Associations,Companies and Societies
• Cancer & Immunology related consultants
• General physicians